The Blanche and Irwin Lerner Center

Research Center

Just as the state of New Jersey is recognized as the nation’s principal pharmaceutical hub, Rutgers Business School (RBS) has evolved as an academic leader in pharmaceutical management training and research. Today, RBS has taken its pioneering role to the next level through the Blanche and Irwin...

Click here to Learn More.

 

Related News, Blogs, and Media Coverage

Pharmacy Choice reports Rutgers Business School BioPharma Case Competition 1st place

Monday, December 8, 2014

Rutgers MBA students Mittal Shah and Sonal Patel were sitting next to one another in Rutgers Business School's Bove Auditorium as the winners of the annual biopharmaceutical case competition were announced on the afternoon of Nov. 14. Within a few minutes, they knew that Kellogg had won third place. And then, Wharton was announced as the second-place winner. The women looked at one another,...

 › Continue Reading

Rutgers Business School MBA students won first place in the annual Rutgers biopharmaceutical case competition reported in New Jersey Business

Wednesday, November 26, 2014

Rutgers University MBA students Mittal Shah and Sonal Patel were sitting next to one another in Rutgers Business School’s Bove Auditorium as the winners of the annual biopharmaceutical case competition were announced. Within a few minutes, they knew that Kellogg had won third place. And then, Wharton was announced as the second-place winner. The women looked at one another, nervously wondering...

 › Continue Reading

Merck's recent strategy shift starting to pay off said Mahmud Hassan in NJ.com

Tuesday, July 29, 2014

Since Merck’s companywide restructuring last fall that included laying off thousands of workers, closing locations and sharpening its focus on research and development, Chief Executive Kenneth Frazier has maintained the sweeping changes would require time to pay off. “In the longer term, we see some good things coming up from the research wing through alliances, through small acquisitions,” said...

 › Continue Reading

Alumni prove to be valuable resource for Pharma MBA student researchers

Wednesday, July 16, 2014

Working with Rutgers Business School Professor Mahmud Hassan, Mark Slomiany, a 2012 MBA graduate, arranged a collaboration between the Blanche and Irwin Lerner Center and the Rutgers Business School Alumni Association to provide three student researchers with the resources of alumni scattered across the biopharmaceutical industry.

 › Continue Reading

Lerner healthcare symposium "validates what we're learning"

Thursday, May 15, 2014

At the annual healthcare symposium sponsored by Rutgers Business School's Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues, many classroom lectures and lessons became a little more meaningful. "We hear about the theory, the legislation, the big picture," said Michael  Kwatkoski, an MBA student in the Pharmaceutical Management Program. "Something like this...

 › Continue Reading

Thought leaders tackle healthcare reform and pharma's changing business model in Lerner Center's annual symposium

Monday, May 5, 2014

The April 30 symposium, "Global Challenges to Pharmaceutical Reimbursements," provided a big-picture, real-world look at the federal government’s efforts to reduce healthcare costs while increasing access to medical care. The symposium is the Blanche and Irwin Lerner Center’s signature event, reinforcing its role as a source of thought leadership on issues impacting the pharmaceutical and healthcare businesses.

 › Continue Reading

Rutgers Business School takes honorable mention at second annual biopharmaceutical case competition

Monday, November 18, 2013

"It was a difficult case, but it was a great learning experience,” Rutgers Business School student Manasa Parakala said after the awards presentation in Bove Auditorium.

 › Continue Reading

Second annual biopharmaceutical case competition attracts teams from nation's top schools

Monday, November 11, 2013

While the case competition is taking place, RBS will also host Pharma Student Day, which features a series of speakers from the pharmaceutical industry and offers students a chance to network. Pharma Student Day is open to all students, alumni and industry professionals. Both events highlight the strength of the Pharmaceutical Management Program and Rutgers Business School’s close ties to the industry.

 › Continue Reading

Mahmud Hassan interviewed about drugmaker Merck's facilities and staff reorganization

Wednesday, October 2, 2013

In a statement about its global cost-cutting plan, Merck, the second-largest U.S. drugmaker said the cuts were part of an effort to sharpen “commercial and R&D (research and development) focus and reduce costs,” including the size of its workforce and global real estate footprint. In a conference call, Merck Chief Executive Ken Frazier said the company will place more emphasis on developing...

 › Continue Reading

Rutgers Pharma MBA ranked one of the Top 10 MBA programs in pharmaceuticals in the world

Monday, September 30, 2013

Rutgers Business School’s MBA in Pharmaceutical Management has been recognized as one of the top 10 MBA programs for Health Care/Pharmaceuticals/Biotechnology in the world according to Find-MBA.com.

 › Continue Reading

Irwin Lerner, who started the Lerner Center at RBS, has high hopes for student research and merger with UMDNJ

Friday, May 3, 2013

Irwin Lerner, the man behind the Blanche and Irwin Lerner Center for the study of Pharmaceutical Management Issues, retired as chairman and chief executive of Roche’s U.S. business in 1992. As he waited for the center’s annual health care symposium to begin at Rutgers Business School, Lerner answered some questions about the pharmaceutical industry in New Jersey, his vision for the center and his reaction to Roche’s exit from Nutley.

 › Continue Reading

Lerner Center's annual symposium addresses bio-pharmaceutical industry's key challenges and trends

Wednesday, May 1, 2013

The healthcare symposium, which the Lerner Center has hosted for nearly a decade, attracted more than 100 people on April 30, including MBA students, Rutgers Business School administrators and employees from drug giants, Celgene, Merck, Johnson & Johnson as well as Ohm Laboratories, the generic drug maker. Mahmud Hassan, a finance professor and director of the Lerner Center, said the symposium is intended to be a setting for “a meaningful dialogue among the bio-pharmaceutical leaders, policy makers and the researchers on issues relevant to the growth of the bio-pharmaceutical industry.”

 › Continue Reading

Healthcare symposium promises to take a hard look at the complex issues facing bio-pharmaceutical industry

Monday, April 22, 2013

The annual symposium, hosted by Rutgers Business School and the Blanche and Irwin Lerner Center for the study of Pharmaceutical Management Issues, will delve into some of the bio-pharmaceutical industry’s most pressing concerns, including the latest innovations to make clinical trials more cost efficient, the progress of FDA efforts to expedite the development of “breakthrough’’ drugs and regulatory crackdowns on the manufacturing of injectable medicines.

 › Continue Reading

Pharma Industry Scholars Program offers distinct advantages to boost career

Friday, February 15, 2013

For select students who choose to concentrate their Rutgers MBA in pharmaceutical management, a unique scholars program offers scholarships to cover the full cost of tuition, internships at some of the world's leading pharmaceutical companies as well as access to professionals in the industry.

 › Continue Reading

Faculty Insight: Ruling by federal appeals court creates new wrinkle for pharmaceutical industry and authorities

Monday, December 17, 2012

A decision by the U.S. Second Circuit Court of Appeals earlier this month stirred up new questions about the controversial issue of off-label marketing. Rutgers Business School Professor Michael Santoro weighed in on the uncertainty and some of the possible implications of the surprise ruling.

 › Continue Reading

Sanofi's Anne Whitaker on leadership and agility during revolutionary change in pharmaceutical industry

Friday, October 26, 2012

As part of the Rutgers Business School's CEO Leadership Series, Anne Whitaker, president of Sanofi's pharmaceutical business in North America, recently spoke about the changes reshaping healthcare industry and the challenges of being a leader during a time of dramatic change.

 › Continue Reading

Rutgers Business School to host its first biopharmaceutical case competition

Tuesday, October 23, 2012

After winning pharmaceutical case competitions at other schools, Rutgers MBA students decided to organize their own event. Mahmud Hassan, a professor in the pharmaceutical management program, said the competition, which is scheduled is "a way of letting the top-ranked business schools know we're a player in this industry..."

 › Continue Reading

Richard Bagger, veteran pharmaceutical executive, joins Lerner Center's advisory board

Thursday, October 11, 2012

The senior vice president of corporate affairs and strategic market access at Summit-based Celgene Corp. said he was delighted to join the board. "I feel it's really important for our state university's business school to focus on issues affecting one of the state's largest economic sectors,'' Bagger said.

 › Continue Reading

Introduction by Dr. Mahmud Hassan at the Rutgers Healthcare Symposium (Part 1 of 5)

Thursday, April 21, 2011

The Annual Healthcare Symposium: "Problems and Prospects of the Pharmaceutical Industry" was held on Thursday, April 21, 2011 at Rutgers Business School in Newark, NJ. The event was made possible by The Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues.

 › Continue Reading

Welcome Address by President Richard McCormick at the Rutgers Healthcare Symposium (Part 2 of 5)

Thursday, April 21, 2011

The Annual Healthcare Symposium: "Problems and Prospects of the Pharmaceutical Industry" was held on Thursday, April 21, 2011 at Rutgers Business School in Newark, NJ. The event was made possible by The Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues.

 › Continue Reading